Klisyri
Tirbanibulin · Almirall, LLC
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Klisyri ingredients
| Active ingredient | Strength |
|---|---|
| Tirbanibulin | 10 mg/g |
What Klisyri is used for
Klisyri is a cancer medicine (microtubule inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Klisyri
- Generic name
- Tirbanibulin
- Made by
- Almirall, LLC
- Forms
- Ointment
- Given
- Topical
- Drug class
- Microtubule Inhibitor
- FDA approval
- New drug application (NDA) NDA213189
- On the US market since
- 2020
Official information
- Klisyri prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Tirbanibulin)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Klisyri?
Klisyri (Tirbanibulin) is a cancer medicine made by Almirall, LLC, approved by the US FDA.
What are the ingredients of Klisyri?
Klisyri contains Tirbanibulin (10 mg/g).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA